An early clinical study shows that a new oral drug is safe and well tolerated in patients with chronic heart failure. The study led by researchers at Karolinska Institutet has been published in The Lancet.
Please follow and like us:
New oral heart failure drug appears to be safe and well tolerated in 58-patient early clinical trial